Analgesia Duration of Dexamethasone, Buprenorphine, or Clonidine With Ropivacaine for Interscalene Nerve Block
Completed · Phase 4
Conditions studied: Anesthesia, Local
In brief
This is a prospective randomized controlled triple-masked study looking at the duration of nerve block analgesia when using the listed adjuvants (dexamethasone, buprenorphine and clonidine) plus ropivacaine versus plain ropivacaine alone.
Key facts
- Study ID
- NCT03117140
- Run by
- Melinda Seering
- People needed
- 160
- Starts
- 2013-12-01
- Expected to finish
- 2017-03-01
- Last updated by the study team
- 2018-07-03
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients who have or are:
- Orthopedics service patients having shoulder surgery
- ASA(American Society of Anesthesiologists) class I, II, or III.
- Patients at least 18 years old but less than 71 years old.
- Patients giving informed consent.
- Non-Emergency Surgery
You may not qualify if…
- Patients who have or are:
- An inability to cooperate during the block placement.
- Neuropathy of the planned extremity to block
- Diabetes
- Documented Kidney Disease
- Documented Liver Disease
- A lack of or inability to give informed consent.
- Currently incarcerated.
- Pregnant
Where it is running
- University of Iowa Hospital and Clinics, Ambulatory Surgery Clinic — Iowa City, Iowa, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.